SEC Company Response from Cardiff Oncology, Inc. (CRDF) (CIK 0001213037) (CRDF) — Jun 5, 2018
Cardiff Oncology, Inc. (CRDF) (CIK 0001213037)
Date: June 5, 2018 · CIK: 0001213037 · Accession: 0001193125-18-184604
AI Filing Summary & Sentiment
File numbers found in text: 333-224808
Letter
ThinkEquity
A division of Fordham Financial Management, Inc.
17 State Street, 22nd Floor
New York, NY 10004
June 5,
VIA EDGAR
U.S. Securities and Exchange Commission
100 F St., NE
Washington, D.C. 20549
Attention: Dorrie Yale
Re: Trovagene, Inc.
Registration Statement on Form S-1 (File No. 333-224808)
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on June 7, 2018, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue.
Very truly yours,
ThinkEquity
Show Raw Text
CORRESP 1 filename1.htm CORRESP ThinkEquity A division of Fordham Financial Management, Inc. 17 State Street, 22nd Floor New York, NY 10004 June 5, 2018 VIA EDGAR U.S. Securities and Exchange Commission 100 F St., NE Washington, D.C. 20549 Attention: Dorrie Yale Re: Trovagene, Inc. Registration Statement on Form S-1 (File No. 333-224808) Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, ThinkEquity, a division of Fordham Financial Management, Inc., as representative of the underwriters, hereby requests acceleration of the effective date of the above-referenced Registration Statement so that it will become effective at 5:00 p.m. Eastern Time on June 7, 2018, or as soon thereafter as practicable. Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus. The undersigned confirms that it has complied with and will continue to comply with, and it has been informed or will be informed by participating dealers that they have complied with or will comply with, Rule 15c2-8 promulgated under the Securities Exchange Act of 1934, as amended, in connection with the above-referenced issue. Very truly yours, ThinkEquity A division of Fordham Financial Management, Inc. By: /s/ Eric Lord Name: Eric Lord Title: Head of Investment Banking